INVESTIGATIONS UNIT
A clinical trial helps the medical community determine whether an investigational drug or treatment is safe and effective in preventing, detecting, or treating a disease or disorder.
We are discovering new horizons for disease treatments.
Studies in Recruitment
-
Ver estudios
Lupus Eritematoso Sistémico
Investigations Unit
We have been developing phase II, III and IV clinical studies since 2005 in the areas of Internal Medicine, Gastroenterology, Cardiology, Nephrology, Hematoloncology, Pulmonology, Endrocrinology and Rheumatology.
We recently ventured into clinical research with medical devices.
We have a great human team made up of professionals committed to research, trained and certified in GCP, IATA; with whom we have contributed to the improvement of treatment for heart failure, diabetes, anti-coagulation, hypercholesterolemia, among others.
Equipped with the necessary medical equipment, power plant and continuous systematized temperature monitoring, among others, we guarantee the greatest efficiency with periodic maintenance from a duly qualified supplier.
Our clients recognize us for our performance in recruitment, high patient retention rates, high satisfaction with our response times, and compliance with the guidelines of our Quality Management System, certified by Berau Veritas.
We have our own Ethics Committee, made up of professionals independent of the institution, with a high level of commitment to the safety and well-being of the participants in clinical studies, with excellent response times, operating with an agile, comfortable and updated virtual platform.
We adhere to the ethical principles of clinical research established in the Helsinki Declaration and in the Good Clinical Practice Guidelines of the International Conference on Harmonization.
Clinical research in Colombia is monitored by Invima. We have Certification in Good Clinical Practices.
We belong to the Colombian Association of Research Centers (ACIC). We are registered with Federal Wide Assurance (FWA) which is a guarantee of compliance with US federal regulations for the protection of human beings.
We have our own Ethics Committee, made up of professionals independent of the institution, with a high level of commitment to the safety and well-being of the participants in clinical studies, with excellent response times, operating with an agile, comfortable and updated virtual platform.
-
Estudios En Los Cuales Hemos Participado
ESTUDIOS REALIZADOS DESDE EL 2007 A FEB 2024
2024_Fase III_Mieloma Múltiple Recidivante o Refractario CA057-008 - SUCCESSOR-2 (Espera Activación)
2023_Fase III_Enfermedad Cardiovascular Confirmada - VICTORION-2P - (En seguimiento)
2023_ Fase III_ Lupus Eritematoso Sistémico 230LE304 TOPAZ (En Reclutamiento)
2022_ Fase IIB_Lupus Eritematoso Sistémico - AMG 592 – 20200234 – (Cerrado)
2022_Fase III Artritis Psoriásica - IM011-055 - (En seguimiento)
2020_Fase IV_Diabetes Mellitus tipo 2 - OBS16039/SUCCESS – (Cerrado)
2019_Fase III_Hemoglobinuria Paroxística Nocturna - APL2-307 - (En seguimiento)
2019_Fase III_Hemoglobinuria Paroxística Nocturna - APL2-308 – (Cerrado)
2019_Fase III_Acidosis Metabólica - TRCA-303 - (Cerrado)
2019_Fase IV_Diabetes Mellitus T1-T2 - OBS15459 – (Cerrado)
2019_Fase III_Lupus Eritematoso Sistémico - I4V-MC-JAIM - (Cerrado)
2018_Fase III_Lupus Eritematoso Sistémico - I4V-MC-JAIA - (Cerrado)
2018_Fase III_Colitis Ulcerativa - SHP647-302- (Cerrado)
2018_Fase III_Colitis Ulcerativa - SHP647-303- (Cerrado)
2018_Fase III_Colitis Ulcerativa - SHP647-304- (En seguimiento)
2018_Fase III_ Enfermedad de Crohn - SHP647-306 - (Cerrado)
2018_Fase III_Enfermedad de Crohn - SHP647-307 - (Cerrado)
2018_Fase III_ Gastroparesia Diabética - RLM-MD-02 - (Cerrado)
2018_Fase III_ Gastroparesia Diabética - RLM-MD-03 - (Cerrado)
2018_Fase III_ Gastroparesia Diabética -RLM-MD-04 - (Cerrado)
2018_Fase III EC o Alto Riesgo de Desarrollarla, que no toleran las Estatinas - CLEAR- (Cerrado)
2018_Fase III Falla Cardiaca Reservada - EMPEROR- (Cerrado)
2018_Fase III_ Falla Cardiaca - GALACTIC - (Cerrado)
2017_Fase III_ Diabetes y enfermedad cardiovascular- VERTIS - (Cerrado)
2016_Fase IV_ Nefropatía Diabética - FIDELIO - (Cerrado)
2016_Fase III_ Nefropatía Diabética - FIGARO - (Cerrado)
2016_Fase IV_ Alto Riesgo Cardiovascular - CARMELINA - (Cerrado)
2015_ Fase III_Alto Riesgo Cardiovascular- SPIRE 1 & SPIRE 2 - (Cerrado)
2015_ Fase IV- Diabetes - DUNE - (Cerrado)
2014_ Fase IV- Fibrilación Auricular- GLORIA - (Cerrado)
2014_ Fase IV- Diabetes- GLOBE - (Cerrado)
2014_ Fase III- Cardiología-FOURIER - (Cerrado)
2014_Fase IIb - Artritis- RA25 - (Cerrado)
2013 _Fase IIIb – Dislipidemia - ODYSSEY / ODYSSEY LEGACY - (Cerrado)
2013_ Fase III – Cardiología_ CANTOS / CANTOS OLE - (Cerrado)
2013 _Fase IIb – Artritis - RA 21 - (Cerrado)
2013 – Fase IIb - Artritis - ARA 2002 - (Cerrado)
2013 _ Fase IV- Epoc- DUST - (Cerrado)
2012 – Fase III - Epoc – SUMMIT - (Cerrado)
2012 – Fase IIb – Artritis- ARA 2001 - (Cerrado)
2012 _ Fase III- Diabetes- ELIXA - (Cerrado)
2012 – Fase III - Asma - LABA - (Cerrado)
2011 – Fase III - ETORICOX - AR- 108 - (Cerrado)
2011 – Fase III - ETORICOX - EA-107 - (Cerrado)
2011 - Fase III - Lupus - ILUMINATE - (Cerrado)
2011 – Fase III - Diabetes - EXSCEL - (Cerrado)
2011 – Fase III - Riesgo Cardiovascular - APOLO - (Cerrado)
2010 – Fase III - Artritis - CENTOCOR - (Cerrado)
2010 – Fase III - Falla Cardiaca - PARADIGMA - (Cerrado)
2009 – Fase III - Diabetes- TECOS - (Cerrado)
2008 – Fase III - Riesgo Cardiovascular HOPE 3 - (Cerrado)
2007 – Fase III - Fibrilación Auricular - ROCKET - (Cerrado)
The world's advances are the result of the discipline and perseverance of those who dedicate their time to research.
Contact
We are at your disposal to offer you more information about our studies and research.
Contact Us
